                         SEQUENCE LISTING

<110>  LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
       CROFT , Michael
       HERRO, Rana
 
<120>  LIGHT Inhibitors for Scleroderma and Skin Fibrotic Disease 
       Treatment

<130>  051501-0445243

<140>  PCT/US16/16784
<141>  2016-02-05

<150>  62/112,571
<151>  2015-02-05

<160>  15    

<170>  PatentIn version 3.5

<210>  1
<211>  240
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Glu Glu Ser Val Val Arg Pro Ser Val Phe Val Val Asp Gly Gln 
1               5                   10                  15      


Thr Asp Ile Pro Phe Thr Arg Leu Gly Arg Ser His Arg Arg Gln Ser 
            20                  25                  30          


Cys Ser Val Ala Arg Val Gly Leu Gly Leu Leu Leu Leu Leu Met Gly 
        35                  40                  45              


Ala Gly Leu Ala Val Gln Gly Trp Phe Leu Leu Gln Leu His Trp Arg 
    50                  55                  60                  


Leu Gly Glu Met Val Thr Arg Leu Pro Asp Gly Pro Ala Gly Ser Trp 
65                  70                  75                  80  


Glu Gln Leu Ile Gln Glu Arg Arg Ser His Glu Val Asn Pro Ala Ala 
                85                  90                  95      


His Leu Thr Gly Ala Asn Ser Ser Leu Thr Gly Ser Gly Gly Pro Leu 
            100                 105                 110         


Leu Trp Glu Thr Gln Leu Gly Leu Ala Phe Leu Arg Gly Leu Ser Tyr 
        115                 120                 125             


His Asp Gly Ala Leu Val Val Thr Lys Ala Gly Tyr Tyr Tyr Ile Tyr 
    130                 135                 140                 


Ser Lys Val Gln Leu Gly Gly Val Gly Cys Pro Leu Gly Leu Ala Ser 
145                 150                 155                 160 


Thr Ile Thr His Gly Leu Tyr Lys Arg Thr Pro Arg Tyr Pro Glu Glu 
                165                 170                 175     


Leu Glu Leu Leu Val Ser Gln Gln Ser Pro Cys Gly Arg Ala Thr Ser 
            180                 185                 190         


Ser Ser Arg Val Trp Trp Asp Ser Ser Phe Leu Gly Gly Val Val His 
        195                 200                 205             


Leu Glu Ala Gly Glu Glu Val Val Val Arg Val Leu Asp Glu Arg Leu 
    210                 215                 220                 


Val Arg Leu Arg Asp Gly Thr Arg Ser Tyr Phe Gly Ala Phe Met Val 
225                 230                 235                 240 


<210>  2
<211>  283
<212>  PRT
<213>  Homo sapiens

<400>  2

Met Glu Pro Pro Gly Asp Trp Gly Pro Pro Pro Trp Arg Ser Thr Pro 
1               5                   10                  15      


Lys Thr Asp Val Leu Arg Leu Val Leu Tyr Leu Thr Phe Leu Gly Ala 
            20                  25                  30          


Pro Cys Tyr Ala Pro Ala Leu Pro Ser Cys Lys Glu Asp Glu Tyr Pro 
        35                  40                  45              


Val Gly Ser Glu Cys Cys Pro Lys Cys Ser Pro Gly Tyr Arg Val Lys 
    50                  55                  60                  


Glu Ala Cys Gly Glu Leu Thr Gly Thr Val Cys Glu Pro Cys Pro Pro 
65                  70                  75                  80  


Gly Thr Tyr Ile Ala His Leu Asn Gly Leu Ser Lys Cys Leu Gln Cys 
                85                  90                  95      


Gln Met Cys Asp Pro Ala Met Gly Leu Arg Ala Ser Arg Asn Cys Ser 
            100                 105                 110         


Arg Thr Glu Asn Ala Val Cys Gly Cys Ser Pro Gly His Phe Cys Ile 
        115                 120                 125             


Val Gln Asp Gly Asp His Cys Ala Ala Cys Arg Ala Tyr Ala Thr Ser 
    130                 135                 140                 


Ser Pro Gly Gln Arg Val Gln Lys Gly Gly Thr Glu Ser Gln Asp Thr 
145                 150                 155                 160 


Leu Cys Gln Asn Cys Pro Pro Gly Thr Phe Ser Pro Asn Gly Thr Leu 
                165                 170                 175     


Glu Glu Cys Gln His Gln Thr Lys Cys Ser Trp Leu Val Thr Lys Ala 
            180                 185                 190         


Gly Ala Gly Thr Ser Ser Ser His Trp Val Trp Trp Phe Leu Ser Gly 
        195                 200                 205             


Ser Leu Val Ile Val Ile Val Cys Ser Thr Val Gly Leu Ile Ile Cys 
    210                 215                 220                 


Val Lys Arg Arg Lys Pro Arg Gly Asp Val Val Lys Val Ile Val Ser 
225                 230                 235                 240 


Val Gln Arg Lys Arg Gln Glu Ala Glu Gly Glu Ala Thr Val Ile Glu 
                245                 250                 255     


Ala Leu Gln Ala Pro Pro Asp Val Thr Thr Val Ala Val Glu Glu Thr 
            260                 265                 270         


Ile Pro Ser Phe Thr Gly Arg Ser Pro Asn His 
        275                 280             


<210>  3
<211>  435
<212>  PRT
<213>  Homo sapiens

<400>  3

Met Leu Leu Pro Trp Ala Thr Ser Ala Pro Gly Leu Ala Trp Gly Pro 
1               5                   10                  15      


Leu Val Leu Gly Leu Phe Gly Leu Leu Ala Ala Ser Gln Pro Gln Ala 
            20                  25                  30          


Val Pro Pro Tyr Ala Ser Glu Asn Gln Thr Cys Arg Asp Gln Glu Lys 
        35                  40                  45              


Glu Tyr Tyr Glu Pro Gln His Arg Ile Cys Cys Ser Arg Cys Pro Pro 
    50                  55                  60                  


Gly Thr Tyr Val Ser Ala Lys Cys Ser Arg Ile Arg Asp Thr Val Cys 
65                  70                  75                  80  


Ala Thr Cys Ala Glu Asn Ser Tyr Asn Glu His Trp Asn Tyr Leu Thr 
                85                  90                  95      


Ile Cys Gln Leu Cys Arg Pro Cys Asp Pro Val Met Gly Leu Glu Glu 
            100                 105                 110         


Ile Ala Pro Cys Thr Ser Lys Arg Lys Thr Gln Cys Arg Cys Gln Pro 
        115                 120                 125             


Gly Met Phe Cys Ala Ala Trp Ala Leu Glu Cys Thr His Cys Glu Leu 
    130                 135                 140                 


Leu Ser Asp Cys Pro Pro Gly Thr Glu Ala Glu Leu Lys Asp Glu Val 
145                 150                 155                 160 


Gly Lys Gly Asn Asn His Cys Val Pro Cys Lys Ala Gly His Phe Gln 
                165                 170                 175     


Asn Thr Ser Ser Pro Ser Ala Arg Cys Gln Pro His Thr Arg Cys Glu 
            180                 185                 190         


Asn Gln Gly Leu Val Glu Ala Ala Pro Gly Thr Ala Gln Ser Asp Thr 
        195                 200                 205             


Thr Cys Lys Asn Pro Leu Glu Pro Leu Pro Pro Glu Met Ser Gly Thr 
    210                 215                 220                 


Met Leu Met Leu Ala Val Leu Leu Pro Leu Ala Phe Phe Leu Leu Leu 
225                 230                 235                 240 


Ala Thr Val Phe Ser Cys Ile Trp Lys Ser His Pro Ser Leu Cys Arg 
                245                 250                 255     


Lys Leu Gly Ser Leu Leu Lys Arg Arg Pro Gln Gly Glu Gly Pro Asn 
            260                 265                 270         


Pro Val Ala Gly Ser Trp Glu Pro Pro Lys Ala His Pro Tyr Phe Pro 
        275                 280                 285             


Asp Leu Val Gln Pro Leu Leu Pro Ile Ser Gly Asp Val Ser Pro Val 
    290                 295                 300                 


Ser Thr Gly Leu Pro Ala Ala Pro Val Leu Glu Ala Gly Val Pro Gln 
305                 310                 315                 320 


Gln Gln Ser Pro Leu Asp Leu Thr Arg Glu Pro Gln Leu Glu Pro Gly 
                325                 330                 335     


Glu Gln Ser Gln Val Ala His Gly Thr Asn Gly Ile His Val Thr Gly 
            340                 345                 350         


Gly Ser Met Thr Ile Thr Gly Asn Ile Tyr Ile Tyr Asn Gly Pro Val 
        355                 360                 365             


Leu Gly Gly Pro Pro Gly Pro Gly Asp Leu Pro Ala Thr Pro Glu Pro 
    370                 375                 380                 


Pro Tyr Pro Ile Pro Glu Glu Gly Asp Pro Gly Pro Pro Gly Leu Ser 
385                 390                 395                 400 


Thr Pro His Gln Glu Asp Gly Lys Ala Trp His Leu Ala Glu Thr Glu 
                405                 410                 415     


His Cys Gly Ala Thr Pro Ser Asn Arg Gly Pro Arg Asn Gln Phe Ile 
            420                 425                 430         


Thr His Asp 
        435 


<210>  4
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artifical Sequence: LIGHT Forward Primer

<400>  4
acagccttca gtgtttgtgg tg                                                22


<210>  5
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artifical Sequence: Reverse Primer

<400>  5
tccggtggtt ctgttccag                                                    19


<210>  6
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artifical Sequence: Collagen Forward Primer

<400>  6
gagccctcgc ttccgtactc                                                   20


<210>  7
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artifical Sequence: Reverse Primer

<400>  7
tgttccctac tcagccgtct gt                                                22


<210>  8
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artifical Sequence: aSMA Forward Primer

<400>  8
tctctatgct aacaacgtcc tgtca                                             25


<210>  9
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artifical Sequence: Reverse Primer

<400>  9
ccaccgatcc agacagagta ctt                                               23


<210>  10
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artifical Sequence: TGF-beta 1 Forward Primer

<400>  10
ccctatattt ggagcctgga                                                   20


<210>  11
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artifical Sequence: Reverse Primer

<400>  11
ggaagcttcg ggatttatgg                                                   20


<210>  12
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artifical Sequence: muTSLP Forward Primer

<400>  12
tcgaggactg tgagagcaag ccag                                              24


<210>  13
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artifical Sequence: Reverse Primer

<400>  13
ctggagattg catgaaggaa tacc                                              24


<210>  14
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artifical Sequence: huTSLP Forward  Primer

<400>  14
tatgagtggg accaaaagta ccg                                               23


<210>  15
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artifical Sequence: Reverse Primer

<400>  15
gggattgaag gttaggctct gg                                                22


